Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for McKesson Corporation (MCK : NYSE)

• Company Description    McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. Number of Employees: 45,000

• Price / Volume Information    Yesterday's Closing Price: $934.75 Daily Weekly Monthly 20 Day Moving Average: 844,088 shares Shares Outstanding: 122.49 (millions) Market Capitalization: $114,495.15 (millions) Beta: 0.40 52 Week High: $971.93 52 Week Low: $585.23 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.22% 12.91% 12 Week 7.94% 4.25% Year To Date 13.95% 14.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6555 STATE HIGHWAY 161 - IRVING,TX 75039 USA ph: 972-446-4800 fax: 415-983-8453 investors@mckesson.com http://www.mckesson.com

• General Corporate Information    Officers Brian S. Tyler - Chief Executive Officer and Director Britt J. Vitalone - Executive Vice President and Chief Financial Offic Napoleon B. Rutledge Jr. - Senior Vice President and Controller James H. Hinton - Director Donald R. Knauss - Director Peer Information McKesson Corporation (ITRJ) McKesson Corporation (BRLI.) McKesson Corporation (GOGY) McKesson Corporation (PSTX.) McKesson Corporation (ELGXQ) McKesson Corporation (CAH) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED/DENTAL-SUPP Sector: Medical CUSIP: 58155Q103 SIC: 5122 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 122.49 Most Recent Split Date: 1.00 (2.00:1) Beta: 0.40 Market Capitalization: $114,495.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.35% Current Fiscal Quarter EPS Consensus Estimate: $11.36 Indicated Annual Dividend: $3.28 Current Fiscal Year EPS Consensus Estimate: $39.03 Payout Ratio: 0.09 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 15.92% Last Dividend Paid: 12/01/2025 - $0.82 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: 23.95 Trailing 12 Months: 24.87 PEG Ratio: 1.50 Price Ratios Price/Book: - Price/Cash Flow: 24.06 Price / Sales: 0.29 EPS Growth vs. Year Ago Period: 16.31% vs. Previous Quarter: -5.27% Sales Growth vs. Year Ago Period: 11.40% vs. Previous Quarter: 2.92% ROE 12/31/25 - -338.97 09/30/25 - -248.14 06/30/25 - -196.66 ROA 12/31/25 - 5.78 09/30/25 - 5.84 06/30/25 - 5.66 Current Ratio 12/31/25 - 0.88 09/30/25 - 0.88 06/30/25 - 0.88 Quick Ratio 12/31/25 - 0.48 09/30/25 - 0.50 06/30/25 - 0.49 Operating Margin 12/31/25 - 1.18 09/30/25 - 1.18 06/30/25 - 1.12 Net Margin 12/31/25 - 1.09 09/30/25 - 1.04 06/30/25 - 0.84 Pre-Tax Margin 12/31/25 - 1.40 09/30/25 - 1.34 06/30/25 - 1.15 Book Value 12/31/25 - -7.36 09/30/25 - -10.89 06/30/25 - -12.69 Inventory Turnover 12/31/25 - 15.16 09/30/25 - 15.23 06/30/25 - 15.16 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©